FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
STLNW
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst Stock AnalysisComprehensive stock analysis for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (STLNW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSTLNW
STLNW
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
STLNW
  1. Home
  2. Stocks
  3. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
ST

Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst

🇺🇸STLNW•NASDAQ
ST

Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst

🇺🇸STLNW•NASDAQ
Market cap
$540.55K

Your view on STLNW

Mkt Cap
$540.55K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst

Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Daniel Virnich
Headquarters
18000 Studebaker Road, Cerritos, CA, US
Industry
Medical - Care Facilities
Sector
Healthcare
CEO
Daniel Virnich
Headquarters
18000 Studebaker Road, Cerritos, CA, US
Description

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.

It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.

It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Starting points for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst: EPS -$0.34, beta 2.95 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Trailing twelve-month EPS for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst stands at -$0.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2024Next quarterDec 2024This yearYear to Dec 2024Next yearYear to Dec 2025
Average estimate−$0.07−$0.08−$0.36−$0.59
Lowest estimate−$0.07−$0.08−$0.37−$0.60
Highest estimate−$0.07−$0.08−$0.35−$0.58
Number of analysts1111
A year ago————
Growth vs a year ago————

Revenue estimates

TotalThis quarterSep 2024Next quarterDec 2024This yearYear to Dec 2024Next yearYear to Dec 2025
Average estimate$107.54M$109.15M$414.70M$500.58M
Lowest estimate$105.66M$107.52M$410.14M$495.07M
Highest estimate$109.38M$111.88M$420.48M$507.55M
Number of analysts2221
A year ago————
Growth vs a year ago————

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold STLNW12 companies
More Medical - Care Facilities companies
TickerTypeCompanySectorExchangeMkt cap
PAOGPAO Group, Inc.HealthcareOTC$12,392
PARKPark Dental Partners, Inc. Common StockHealthcareNASDAQ$94.3M
PHMBPharmaCom BioVet, Inc.HealthcareOTC$1.1M
PIIIP3 Health Partners Inc.HealthcareNASDAQ$5.5M
PIIIWP3 Health Partners Inc.HealthcareNASDAQ$2.0M
PIQ.AXProteomics International Laboratories Ltd.HealthcareASX—
PMHSPolomar Health Services, Inc.HealthcareOTC$4.5M
PNTGThe Pennant Group, Inc.HealthcareNASDAQ$1.2B
PRMDPrimemd Inc.HealthcareOTC$12,949
RAFLFRaffles Medical Group LtdHealthcareOTC$1.4B
REG.AXRegis Healthcare LimitedHealthcareASX—
RHC.AXRamsay Health Care LimitedHealthcareASX—
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst.

STLNW AnalysisWeak
Past
1
Growth
2
Health
1
Profit
1
Value
1